Current Controversies in Infective Endocarditis

Current Controversies in Infective Endocarditis

October 20, 2014 at 9:42 AM 0 comments

Lampson Fan, Bernard Prendergast, *Neil Herring Oxford Heart Centre, The John Radcliffe Hospital, Oxford University NHS Trust, Headington, Oxford, UK *Correspondence to neilherring@doctors.org.uk Disclosure: No potential conflict of interest. Received: 21.04.14 Accepted: 08.07.14 Citation: EMJ Cardiol. 2014;2:105-113. Abstract Infective endocarditis (IE) remains a devastating disease with a high mortality. ItsRead More

Novel Anticoagulants in Atrial Fibrillation

Novel Anticoagulants in Atrial Fibrillation

February 21, 2014 at 2:30 PM 0 comments

Summary of the Presentations from the Daiichi Sankyo Symposium, AHA Congress 2013, Dallas, Texas, USA  Chairperson: Eugene Braunwald1 Speakers: Elaine Hylek,2 Jeffrey Weitz,3 Robert Giugliano,4 Christian Ruff,5 John Camm6 1. Professor of Medicine, Harvard Medical School, Boston, USA 2. Professor of Medicine, Boston University, Boston, USA 3. Professor of Medicine and Biochemistry,Read More

Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results

Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results

February 21, 2014 at 2:26 PM 0 comments

Robert Giugliano Associate Professor of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA Citation: EMJ Cardiol;1(Suppl 1):6-7 Presentation Summary The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results. It was presented on 19th November 2013 atRead More

Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions

Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions

October 17, 2013 at 2:27 PM 0 comments

Summary of Presentations from the Menarini Symposium, ESC Annual Congress 2013, Amsterdam, the Netherlands Chairperson: Giuseppe Mancia1 Speakers: Krzysztof Narkiewicz2, Athanasios J. Manolis3, Claudio Borghi4 1. Department of Internal Medicine and Cardiovascular Prevention, S. Gerardo Hospital, Milan, Italy 2. Medical University of Gdansk, Poland 3. Director, Cardiology Department, Asklepeion Hospital, Athens, Greece 4. DepartmentRead More

Consistency Versus Equity – Cardiovascular Disease Management For South Asians in the United Kingdom

Consistency Versus Equity – Cardiovascular Disease Management For South Asians in the United Kingdom

October 10, 2013 at 10:01 PM 0 comments

Jeetesh V. Patel,1,2 Paul Flinders,1 Brian D.A. Gammon,2 Girish S. Dwivedi,3 Richard P. Steeds3 1. School of Medicine, University of Nottingham, Nottingham, UK 2. Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK 3. Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK Disclosure: No potential conflict of interest.Read More

Managing Thromboembolic Risks of Atrial Fibrillation – Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices

Managing Thromboembolic Risks of Atrial Fibrillation – Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices

October 10, 2013 at 8:03 PM 0 comments

Bela Merkely,1 Eszter M. Vegh,2 Attila Roka2 1. Director, Heart Center, Semmelweis University, Budapest, Hungary 2. Massachusetts General Hospital, Boston, MA, United States Disclosure: No potential conflict of interest. Received: 22.08.13 Accepted: 10.10.13 Citation: EMJ Cardiol. 2013;1:77-81. Abstract Ischaemic/embolic complications are the most common severeRead More

The Changing Landscape in Oral Anticoagulation – The Last Pieces of the Puzzle

The Changing Landscape in Oral Anticoagulation – The Last Pieces of the Puzzle

October 10, 2013 at 7:58 PM 0 comments

Summary of Presentations from the Daiichi Sankyo Symposium, ESC Annual Congress 2013, Amsterdam, the Netherlands Chairperson: A. John Camm,1 Jeffrey I. Weitz,2 Speakers: Raffaele De Caterina,3 Hein Heidbüchel,4 Robert P. Giugliano,5 Harry R. Büller6 1. Professor of Clinical Cardiology, St George’s Hospital, London, UK 2. Professor, Division of Haematology and Thromboembolism, Department of Medicine,Read More

The Benefits of Rivaroxaban (Xarelto®) Across Multiple Indications and the Relevance to Cardiologists

The Benefits of Rivaroxaban (Xarelto®) Across Multiple Indications and the Relevance to Cardiologists

October 7, 2013 at 10:24 PM 0 comments

Ingo Ahrens, Christoph Bode Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany Disclosure: Authors have received speaker’s honoraria from Bayer Healthcare, Lilly, Sanofi Aventis, Daiichi Sankyo, Merck, and Astra-Zeneca. Received: 29.08.13 Accepted: 07.10.13 Citation: EMJ Cardiol. 2013;1:XX-XX. Abstract Oral anticoagulation with vitamin-K-antagonists has well known limitations and requires routineRead More

Initial Evidence in Thromboangiitis Obliterans (Buerger’s Disease) Treatment with Bosentan

Initial Evidence in Thromboangiitis Obliterans (Buerger’s Disease) Treatment with Bosentan

September 11, 2013 at 10:11 PM 0 comments

Joaquín de Haro, Silvia Bleda, Francisco Acin Vascular Surgery and Angiology Department, Hospital Universitario Getafe, Madrid, Spain Disclosure: No potential conflict of interest. Received: 01.06.2013 Accepted: 11.09.2013 Citation: EMJ Cardiol. 2013;1:96-100. Abstract Thromboangiitis obliterans (TAO) is a vascular disease that affects small and medium-sized arteries and veins of both upperRead More

New Insights into the Definitive Management of Venous Thromboembolism

New Insights into the Definitive Management of Venous Thromboembolism

September 7, 2013 at 2:20 PM 0 comments

Summary of the Presentations from the Daiichi Sankyo Symposium, ESC Congress 2013, Amsterdam, the Netherlands Chairperson: Valentin Fuster1 Speakers: Ajay K. Kakkar,2 Gregory Y. H. Lip,3 Ander Cohen,4 Harry R. Büller5 1. Director of Mount Sinai Heart at the Mount Sinai Medical Center, Chicago, USA 2. Professor of Surgery, University College London, UK 3. ProfessorRead More